4th Molecular Diagnostics for Cancer Drug Development
Meet the oncology and diagnostics experts you need to deliver better, safer drugs to market quicker
25 - 28 June 2012, Boston
www.moleculardiagnostics-cancer.com
Featuring 31 expert speakers, including:
This meeting will profile those at the cutting edge of personalized medicine in oncology to give you a thorough review of best practice in end to end drug and diagnostic development from discovery to commercialization.
For more information please visit the website: www.moleculardiagnostics-cancer.com or get in touch on [email protected].
Josh Lowth
Hanson Wade
Meet the oncology and diagnostics experts you need to deliver better, safer drugs to market quicker
25 - 28 June 2012, Boston
www.moleculardiagnostics-cancer.com
Featuring 31 expert speakers, including:
- Dr Richard Buller, Vice President, Translational Oncology, Pfizer
- Dr Miu Chau, Global Head, Companion Diagnostics Operations, Genentech
- Dr Mitch Raponi, Senior Director, Molecular Diagnostics & Translational Medicine, Clovis Oncology
This meeting will profile those at the cutting edge of personalized medicine in oncology to give you a thorough review of best practice in end to end drug and diagnostic development from discovery to commercialization.
For more information please visit the website: www.moleculardiagnostics-cancer.com or get in touch on [email protected].
Josh Lowth
Hanson Wade